The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes

被引:152
作者
Curtis, BM
Ravani, P
Malberti, F
Kennett, F
Taylor, PA
Djurdjev, O
Levin, A
机构
[1] Univ British Columbia, St Pauls Hosp, CHEOS, Vancouver, BC V6Z 1Y6, Canada
[2] Mem Univ Newfoundland, Patient Res Ctr, Div Nephrol, St John, NF A1C 5S7, Canada
[3] Univ British Columbia, St Pauls Hosp, Div Nephrol, Vancouver, BC V6Z 1Y6, Canada
关键词
chronic disease management; chronic kidney disease; multi-disciplinary clinic; nephrology; outcomes; survival;
D O I
10.1093/ndt/gfh585
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. This two country case control study of incident dialysis patients evaluates the outcomes of patients exposed to formalized multi-disciplinary clinic (MDC) programmes vs standard nephrologist care. Methods. Patients commencing dialysis in two centres (Vancouver, Canada and Cremona, Italy) were evaluated at and after dialysis start, as a function of MDC exposure vs nephrologist care alone. Only chronic kidney disease patients, with longer than 3 months of exposure to nephrology care, who had not previously received kidney replacement therapy were included. Study outcomes included laboratory parameters and survival. The MDC was similar in both countries and average exposure was 6-8 h per patient-year, as compared to 2-4 h for standard care. All patients had equal access to resources prior to dialysis and with respect to dialysis start, as all had been referred to the same local nephrology practices. Results. During the evaluation period 288 patients commenced dialysis after receiving more than 3 months nephrology care prior to dialysis. There were no major demographic differences between the cohorts. Mean duration of nephrology care prior to dialysis was 42 months, and dialysis was initiated at similar low glomerular filtration rate (GFR), though statistically significantly different (7.0 and 8.4 ml/min/m(2), P=0.001). The MDC patients had higher haemoglobin (102 vs 90 g/l, P < 0.0001), albumin (37.0 vs 34.8 g/l, P=0.002) and calcium levels (2.29 vs 2.16 mmol/l, P<0.0001) at dialysis start. Survival was significantly better in the MDC group demonstrated by Kaplan-Meier analysis (P=0.01). Cox proportional hazards analysis demonstrated standard nephrology clinic vs MDC attendance was a statistically significant independent predictor of death (hazards ratio = 2.17, 95 % confidence interval 1.11-4.28) after adjusting for other variables known to impact outcomes. Conclusions. This analysis of outcomes in two different countries suggests that despite equal and long exposure to nephrology care prior to dialysis, there appears to be an association of survival advantage for those patients exposed to formalized clinic care in addition to standard nephrologist follow-up. While other known predictors of survival such as adequacy of dialysis and severity of illness measures were not included in the model, those parameters require time on dialysis to be accumulated. Thus, the data do suggest that knowledge of patient status at the time of dialysis start is important. Further research is needed to determine which specific components of care both prior to dialysis and after its commencement are most important with respect to outcomes.
引用
收藏
页码:147 / 154
页数:8
相关论文
共 36 条
  • [1] Prediction of early death in end-stage renal disease patients starting dialysis
    Barrett, BJ
    Parfrey, PS
    Morgan, J
    Barre, P
    Fine, A
    Goldstein, MB
    Handa, SP
    Jindal, KK
    Kjellstrand, CM
    Levin, A
    Mandin, H
    Muirhead, N
    Richardson, RMA
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 29 (02) : 214 - 222
  • [2] *CAN I HLTH INF CA, 2001, 2001 REP, V1
  • [3] Abysmal prognosis of patients with type 2 diabetes entering dialysis
    Chantrel, F
    Enache, I
    Bouiller, M
    Kolb, I
    Kunz, K
    Petitjean, P
    Moulin, B
    Hannedouche, T
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (01) : 129 - 136
  • [4] CHURCHILL DN, 1999, J AM SOC NEPHROL S13, V10
  • [5] Curtis BM, 2002, CLIN NEPHROL, V58, P282
  • [6] How can the cardiac death rate be reduced in dialysis patients?
    Curtis, BM
    Parfrey, PS
    [J]. SEMINARS IN DIALYSIS, 2002, 15 (01) : 22 - 24
  • [7] Use of erythropoietin before the initiation of dialysis and its impact on mortality
    Fink, JC
    Blahut, SA
    Reddy, M
    Light, PD
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (02) : 348 - 355
  • [8] Gabel M, 1997, CANCER, V79, P2380
  • [9] Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
    Gaede, P
    Vedel, P
    Larsen, N
    Jensen, GVH
    Parving, H
    Pedersen, O
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) : 383 - 393
  • [10] Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria:: the Steno type 2 randomised study
    Gæde, P
    Vedel, P
    Parving, HH
    Pedersen, O
    [J]. LANCET, 1999, 353 (9153) : 617 - 622